摘要

The discussion presented here is a summary of the debate given at the combined Stroke Society of Australasia and Smart Strokes meeting in 2015. In summary, the evidence for blood pressure lowering at discharge has been extrapolated from clinical trial performed in the latter phase of stroke. Evidence of harm from early commencing blood pressure therapy was provided. The debate ended with emphasis on personalized medicine and proposal for other avenues to improve the use of secondary stroke prevention strategies.

  • 出版日期2017-2